659 related articles for article (PubMed ID: 16107144)
1. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
2. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
Bissantz C; Bernard P; Hibert M; Rognan D
Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
[TBL] [Abstract][Full Text] [Related]
3. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
Radestock S; Weil T; Renner S
J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
[TBL] [Abstract][Full Text] [Related]
4. PREDICT modeling and in-silico screening for G-protein coupled receptors.
Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
[TBL] [Abstract][Full Text] [Related]
5. Multiple-ligand-based virtual screening: methods and applications of the MTree approach.
Hessler G; Zimmermann M; Matter H; Evers A; Naumann T; Lengauer T; Rarey M
J Med Chem; 2005 Oct; 48(21):6575-84. PubMed ID: 16220974
[TBL] [Abstract][Full Text] [Related]
6. Ligand-based structural hypotheses for virtual screening.
Jain AN
J Med Chem; 2004 Feb; 47(4):947-61. PubMed ID: 14761196
[TBL] [Abstract][Full Text] [Related]
7. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
Klabunde T; Giegerich C; Evers A
J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
[TBL] [Abstract][Full Text] [Related]
8. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.
Evers A; Klabunde T
J Med Chem; 2005 Feb; 48(4):1088-97. PubMed ID: 15715476
[TBL] [Abstract][Full Text] [Related]
9. GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects.
Klabunde T; Evers A
Chembiochem; 2005 May; 6(5):876-89. PubMed ID: 15791686
[TBL] [Abstract][Full Text] [Related]
10. Drug design strategies for targeting G-protein-coupled receptors.
Klabunde T; Hessler G
Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
[TBL] [Abstract][Full Text] [Related]
11. Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods.
Bissantz C; Schalon C; Guba W; Stahl M
Proteins; 2005 Dec; 61(4):938-52. PubMed ID: 16224780
[TBL] [Abstract][Full Text] [Related]
12. GPCR structure-based virtual screening approach for CB2 antagonist search.
Chen JZ; Wang J; Xie XQ
J Chem Inf Model; 2007; 47(4):1626-37. PubMed ID: 17580929
[TBL] [Abstract][Full Text] [Related]
13. Finding ligands for G protein-coupled receptors based on the protein-compound affinity matrix.
Fukunishi Y; Kubota S; Nakamura H
J Mol Graph Model; 2007 Jan; 25(5):633-43. PubMed ID: 16777448
[TBL] [Abstract][Full Text] [Related]
14. Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors.
Krüger DM; Evers A
ChemMedChem; 2010 Jan; 5(1):148-58. PubMed ID: 19908272
[TBL] [Abstract][Full Text] [Related]
15. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
16. Virtual screen for ligands of orphan G protein-coupled receptors.
Bock JR; Gough DA
J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
[TBL] [Abstract][Full Text] [Related]
17. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring.
Zhang Q; Muegge I
J Med Chem; 2006 Mar; 49(5):1536-48. PubMed ID: 16509572
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
19. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
Askjaer S; Langgård M
J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
[TBL] [Abstract][Full Text] [Related]
20. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
